FGF21 and liver disorder: FGF21 analogs, such as pegbelfermin, have demonstrated effectiveness in increasing hepatic fatty acid oxidation (FAO), reducing lipotoxicity, and preventing fibrosis in metabolic disease models, highlighting their potential application in treating cirrhosis and other liver disorders.